This chemical is primarily used in peptide synthesis, particularly in solid-phase peptide synthesis (SPPS) methods. Its Fmoc (fluorenylmethyloxycarbonyl) protecting group allows for selective deprotection during the synthesis process, enabling the sequential addition of amino acids to build peptides. The presence of fluorine atoms in the structure can enhance the stability and binding affinity of the resulting peptides, making it valuable in the development of peptide-based drugs and bioactive molecules. It is often employed in research focused on creating peptides with specific biological activities or improved pharmacokinetic properties, such as those used in therapeutic applications or biochemical studies.